Announcement|Articles in Press

In Memoriam

    Open AccessPublished:May 24, 2023DOI:
        This paper is only available as a PDF. To read, Please Download here.

        Linked Article

        • Drug discovery efforts at George Mason University
          SLAS Discovery
          • Preview
            With over 39,000 students, and research expenditures in excess of $200 million, George Mason University (GMU) is the largest R1 (Carnegie Classification of very high research activity) university in Virginia. Mason scientists have been involved in the discovery and development of novel diagnostics and therapeutics in areas as diverse as infectious diseases and cancer. Below are highlights of the efforts being led by Mason researchers in the drug discovery arena. To enable targeted cellular delivery, and non-biomedical applications, Veneziano and colleagues have developed a synthesis strategy that enables the design of self-assembling DNA nanoparticles (DNA origami) with prescribed shape and size in the 10 to 100 nm range.
          • Full-Text
          • PDF
          Open Access